Medical Ethics
RSSArticles
When IRBs Take a Walk on the Wild Side: The Dark Web
What many IRBs might not know is that researchers increasingly are turning to the “dark web” for data.
Sample Checklist from Tribal IRB Toolkit
The Collaborative Research Center for American Indian Health Tribal IRB Toolkit contains 101 pages, covering all aspects of initiating and running an IRB.
Research Institution Works With Native American Tribes to Streamline IRB Review
The Havasupai Tribe’s 1994 lawsuit against Arizona State University researchers and the institution illustrated some of the particular problems and challenges related to research involving Native American tribes.
AAMC Official Discusses Implications of Laws that Target Fetal Tissue Research
Research involving fetal tissue increasingly could be affected by new state regulations.
NIH Designates LGBT Community as Health Disparity Group
The National Institutes of Health’s recent decision to designate sexual and gender minorities as a “disparity” population for research purposes was welcomed by researchers and advocates for the LGBT community.
IRBs Should Ensure that Proposed Studies Include Whether Research is ‘Reproducible’
An emerging body of research reveals that past studies — some of which may form the basis of current policies and recommendations — cannot be replicated by investigators today.
Big Sugar’s Smoking Gun
Though the influence of industry funding on research outcomes has long been a subject of concern for IRBs, it is unusual to find a “smoking gun” strongly linking an undisclosed funding source to biased research outcomes.
Historical Exposé on Sugar Industry Funding Research has Relevant Lessons for Current IRBs
A recently published study linking secret funding by the sugar industry to bias in research studies published in the 1960s is less a historical curiosity than a clear warning to IRBs to remain vigilant about conflicts of interest.
Highlights from Final Rule on Clinical Trial Results Submissions
The NIH published the final rule, “Clinical Trials Registration and Results Information Submission,” on Sept. 21, 2016, with an effective date of Jan. 18, 2017.
New NIH/FDA Rules Will Bring Greater Transparency to Clinical Trials
The new rules published this fall by the NIH and FDA about reporting clinical trial results will expand transparency in research and give the world more knowledge about the effectiveness of investigational and new drugs and devices, FDA and NIH officials say.